Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3114 results found
Expand All
Apply All
3114 results found

Good Day BIO: HHS' payment models, long COVID symptoms, and more
Share
Good Day BIO Newsletter  •  February 15, 2023
HHS will test three pilot payment models—here’s BIO’s take. Plus, reactions to Mexico’s modified biotech corn ban and what you need to know about long COVID symptoms and R&D. (699 words, 3 minutes, 29 seconds)
Read More

BIO Statement: Mexico's New Decree Falls Short
Share
Press Release  •  February 14, 2023
Mexico’s new decree creates more questions than answers. The decree still wrongly calls into question the safety of products of agricultural biotechnology for human consumption by creating a non-science-based distinction of corn used for food and corn used for feed and industrial uses. The decree also does not provide any commitment that Mexico’s regulators will return to a science- and risk-based regulatory approval process for all agricultural biotechnology products in the future. BIO appreciates the U.S. government’s ongoing efforts to hold Mexico to its USMCA commitments and its recent request that Mexico provide the justification behind its past decree on biotech corn and the rejections of new biotech seed traits. While BIO has supported dialogue to resolve this issue, it has become necessary for USTR to request consultations with Mexico over its treatment of agricultural biotechnology in order to provide a framework and timeline to resolve this issue.
Read More

Good Day BIO: Mexico's new decree on biotech corn
Share
Good Day BIO Newsletter  •  February 14, 2023
Happy Valentine’s Day. We have a new development on Mexico’s corn ban, insights on why we need to update vaccine policy, and a lot more news. (667 words, 3 minutes, 20 seconds)
Read More

BIO Comments to CMS on the Proposed Rule Dealing with Medicare Drug Pricing
Share
Letters, Testimony & Comments  •  February 13, 2023
BIO’s comments on specific aspects of CMS’s Proposed Rule on Medicaid drug pricing are presented below.
Read More

Good Day BIO: Mexico must 'explain the science' on corn ban – plus, state legislatures preview
Share
Good Day BIO Newsletter  •  February 13, 2023
The U.S. told Mexico it has until tomorrow to explain the science behind the biotech corn ban—something BIO’s long called for. Plus, we have an exclusive look at what to expect in the state legislatures in 2023. (Hint: A lot of vaccine-related bills.) (642 words, 3 minutes, 12 seconds)
Read More

Good Day BIO: CMS releases timeline for inflation rebate on drug price increases
Share
Good Day BIO Newsletter  •  February 10, 2023
A busy Friday: CMS released its timeline for penalizing drug price increases, BIO submitted comments on the importance of IP, and experts highlight RSV vaccine development and the fungal crisis. (826 words, 4 minutes, 7 seconds)
Read More

Good Day BIO: What happened at yesterday's hearing on the COVID-19 response
Share
Good Day BIO Newsletter  •  February 9, 2023
Recapping yesterday’s hearing on the federal COVID-19 response as well as what we learned about the future of clinical trials at the BIO CEO and Investor Conference. (742 words, 3 minutes, 42 seconds)
Read More

Good Day BIO: State of the Union takeaways
Share
Good Day BIO Newsletter  •  February 8, 2023
We recap what Biden said (or didn’t say) about biotech in the State of the Union, and Day 2 of the BIO CEO and Investor Conference, where drug price controls put a damper on an otherwise optimistic outlook. (663 words, 3 minutes, 18 seconds)
Read More

Good Day BIO: Is biotech still a good investment?
Share
Good Day BIO Newsletter  •  February 7, 2023
Day 1 of the BIO CEO and Investor Conference brought optimism about the industry and the market outlook—and a look at a new program that will ignite innovation. We tell you how to follow Day 2 and more below. (640 words, 2 minutes, 12 seconds)
Read More

Good Day BIO: Investment in pain and addiction falls short
Share
Good Day BIO Newsletter  •  February 6, 2023
Greetings from the BIO CEO and Investor Conference in New York! BIO’s new report on the state of pain and addiction shows a dire need for investment—we have more details. Last week, BIO responded to the Biden administration’s RFI on biotech regulation, explaining how technology can stimulate the economy and further big societal goals. (655 words, 3 minutes, 16 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 110
  • 111
  • 112
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO